Applications of 2,3,4,6-Tetra-O-Acetyl-Beta-D-Glucopyranosyl Isothiocyanate in Industrial Manufacturing

Our facility supplies 2,3,4,6-Tetra-O-Acetyl-Beta-D-Glucopyranosyl Isothiocyanate to specialized downstream manufacturers requiring precise glycosyl isothiocyanate functionality. Below are key industrial applications based on true sector demand, each informed by established compliance, formulation experience, and integrated process requirements.

1. Glycosylated Isothiocyanate Intermediates for Anticancer API Synthesis

Pharmaceutical manufacturers use this compound to introduce isothiocyanate groups into glycoside-based drug intermediates, notably for targeted anticancer agents. The raw material supports selective conjugation during multi-step API synthesis, especially for molecules aiming for improved cell uptake or prodrug performance. GMP plants employ strict control over reaction stoichiometry and impurity profiles, with multi-point QC sampling aligned to clinical manufacturing needs.

Industry compliance standards

• ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
• USP & EP monographs for intermediates and APIs
• 21 CFR Part 211 (FDA cGMP for finished pharmaceuticals)
• Chinese Pharmacopoeia compliance for oncology intermediates

Typical usage ratio

• 0.5–2.0 molar equivalents per core intermediate, with adjustment based on isothiocyanate introduction efficiency and downstream hydrolysis tolerance requirements

Downstream process integration

• Reaction step: Direct glycosylation with protected sugar moiety under anhydrous conditions, typically in solvent-phase synthesis
• Purification: Flash chromatography or crystallization to isolate the protected glycosyl isothiocyanate intermediate
• Succeeding deprotection and coupling steps for final API construction

Final product types

• Glycosylated isothiocyanate API intermediates
• Clinical-stage anticancer drug substances
• Prodrug formulations for enhanced pharmacokinetics

2. Carbohydrate-Based Probes and Labels for Biotechnology Assays

Biotech assay kit producers apply this compound as a protected glycosyl isothiocyanate source for synthesis of carbohydrate probes. Its reactivity enables covalent labeling strategies for glycoprotein analysis, cell trafficking studies, or biomolecule surface modification. Formulators optimize the acetyl protection to prevent side reactions, maintaining assay sensitivity. Batch records require process traceability for research reagent supply.

Industry compliance standards

• ISO 13485 Quality Management Systems for Medical Devices (biological reagents)
• REACH Regulation for research chemical supply
• ELISA and diagnostic kit validation protocols
• Certificate of Analysis traceability (COA, lot-to-lot)

Typical usage ratio

• 5–20 mg per 1 mL labeling solution, depending on target probe density and biomolecule type
• May vary based on desired conjugation efficiency and degree of substitution

Downstream process integration

• Activation: Deprotection in mild base or with hydrazine to generate reactive glycosyl group
• Covalent attachment: Conjugation to protein or peptide targets, followed by desalting/purification
• Assay construction: Inclusion of labeled probe in ELISA or detection format

Final product types

• Glycosyl isothiocyanate-conjugated antibody probes
• Diagnostic microarrays
• Fluorescent or chromogenic research assay kits

3. Flavor and Aroma Precursors in Food Ingredient Development

Food ingredient formulator companies exploit the compound as a masked isothiocyanate donor, serving as a precursor for controlled release of flavor-active compounds. The acetyl-protected glycosyl structure provides stability during processing, with controlled deacetylation enabling flavor release in response to enzymatic or thermal triggers during food preparation. Compliance ensures food-grade sourcing, with focus on trace residues and absence of reaction by-products.

Industry compliance standards

• FDA 21 CFR Part 170-199 (Food Additives regulations)
• EU Regulation (EC) No 1334/2008 on flavorings
• FSSC 22000 or ISO 22000 Food Safety Management certification
• JECFA (Joint FAO/WHO Expert Committee on Food Additives) approval for precursors

Typical usage ratio

• 0.01–0.1% w/w in formulated spice or condiment bases, subject to local regulatory maximums for glycosyl isothiocyanate derivatives
• Benchmarked via sensory and GC-MS aroma release assays

Downstream process integration

• Pre-mix: Blend into dry spice or liquid base formula under low-moisture conditions
• Processing: Deacetylation by controlled heating or enzymatic addition during final food manufacturing
• Quality control: Analytical verification of isothiocyanate release during shelf-life and culinary trials

Final product types

• Mustard and horseradish-style flavoring powders
• Condiment concentrates for prepared food
• Spice blends with time-release aroma profiles

4. Glycosyl Donor Building Blocks in Oligosaccharide Synthesis

Specialty carbohydrate chemistry labs and advanced API producers select this material as a protected glycosyl donor for constructing structurally complex oligosaccharides. Its acetylation pattern allows for precise control of glycosidic linkage formation via enzymatic or chemical activation routes. Process chemists strictly monitor coupling yields and anomeric selectivity, integrating multi-step protection and deprotection routines under GMP, especially for vaccine and diagnostic component supply.

Industry compliance standards

• ICH Q11 (Development and Manufacture of Drug Substances)
• USP-NF for carbohydrate excipients and intermediates
• ISO 9001 Quality Systems (custom synthesis supply)
• Applicable local chemical registration and handling legislation

Typical usage ratio

• 1–2 equivalents per acceptor molecule in glycosylation steps, adjusted for desired oligomer length and chain branching

Downstream process integration

• Activation: Promoter-assisted glycosylation (e.g., with triflate, Lewis acid, or enzyme catalysis)
• Oligosaccharide assembly: Stepwise coupling with controlled purification after each addition
• Global deprotection post-assembly, leading to target structure isolation

Final product types

• Glycan standards for pharmaceutical QC
• Immunogenic oligosaccharide fragments for vaccines
• Complex sugar moieties for diagnostic enzyme substrates